AI Startup ReportAId Secures €2.2M in Pre-Seed Investment

ReportAId, a cutting-edge company based in Milan, Italy, has secured €2.2M in Pre-Seed funding to enhance healthcare processes through the power of artificial intelligence (AI).

The investment round was spearheaded by Italian Founders Fund, with contributions from Heartfelt, Exceptional Ventures, 2100 Ventures, Vento, Ithaca, B Heroes, Vesper Holding, and prominent angel investors including Luca Ascani, Enrico Giacomelli, Francesco Zaccariello, and Luca Foschini.

The primary goal for ReportAId with this funding is to expand its team by hiring ten new members and extend its reach within the Italian and European healthcare sectors.

Established in Milan in 2024 by Giuseppe Faraci as CEO, Claudio Caletti as CTO, and Luca Foresti as Chairman, ReportAId specializes in leveraging AI technology to streamline healthcare processes. The company’s innovative approach involves automatically interpreting medical reports and transforming them into interactive tools for both healthcare providers and patients, all while ensuring full compliance with European privacy regulations. By utilizing AI to analyze unstructured clinical data, ReportAId has developed a solution that not only enhances the patient experience but also delivers substantial operational benefits to healthcare providers. Hospitals using the system have reported revenue increases of up to 25%.

Looking towards the future, ReportAId plans to enhance its integration capabilities with existing healthcare IT systems, develop additional AI features tailored to specific medical fields, and collaborate with public healthcare authorities to implement its solution on a larger scale. This strategic approach aims to create a more efficient and accessible healthcare system that prioritizes patient care, reduces costs, and minimizes administrative burdens.

Stay tuned for more updates from ReportAId as they continue to revolutionize the healthcare industry with AI-driven solutions.

FinSMEs

06/05/2025